Valvular Heart Disease
Scientific Statement | Acute heart failure and valvular heart disease
30 May, 2023 | 11:53h | UTC
RCT | Apixaban fails to match warfarin in preventing valve thrombosis in On-X mechanical heart valve patients
22 May, 2023 | 13:44h | UTCApixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve – NEJM Evidence
Commentary: Apixaban or Warfarin in Patients With On-X Mechanical Aortic Valve – American College of Cardiology
Commentary on Twitter
“…in patients with an On-X mechanical aortic valve, apixaban was not noninferior to warfarin and failed to meet our safety threshold… for the prevention of valve thrombosis or valve-related thromboembolism.” https://t.co/XEcOJiGIYU#CardioTwitter #Afib
— NEJM Evidence (@NEJMEvidence) May 11, 2023
Formal consensus study on surgery to replace the aortic valve in adults aged 18–60 years
10 May, 2023 | 15:38h | UTCFormal consensus study on surgery to replace the aortic valve in adults aged 18–60 years – Heart
Commentary on Twitter
Formal consensus study on surgery to replace the aortic valve in adults aged 18–60 years https://t.co/69qlooAuhp pic.twitter.com/6hVWMElYqq
— Heart_BMJ (@Heart_BMJ) April 23, 2023
Review | Challenges in cardiology: diagnosis of native and prosthetic valve endocarditis
9 May, 2023 | 14:19h | UTCSee all articles in the series here
Review | DOACs and rheumatic valvulopathy: always a red light?
9 May, 2023 | 14:15h | UTCDOACs and rheumatic valvulopathy: always a red light? – European Heart Journal Supplements
See all articles in the series here
Expert Panel | Appropriate use criteria for the management of aortic stenosis
5 May, 2023 | 15:22h | UTC
Perspective | Proposal of a model of care for outpatient antimicrobial therapy for infective endocarditis
12 Apr, 2023 | 13:08h | UTCOutpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care – Antibiotics
Commentary on Twitter
🆕️⚡️ @antibioticsmdpi
Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care#IDTwitter #IEWikiguidelines https://t.co/uI88p1l7nR pic.twitter.com/2JiFTKR5fr— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) February 10, 2023
Rheumatic heart disease: JACC focus seminar
6 Apr, 2023 | 13:17h | UTCRheumatic Heart Disease: JACC Focus Seminar – Journal of the American College of Cardiology
Review | Multi-modality cardiac imaging evaluation of infective endocarditis
30 Mar, 2023 | 14:05h | UTCContemporary Review of Multi-Modality Cardiac Imaging Evaluation of Infective Endocarditis – Life
SR | Diagnostic accuracy of heart auscultation for detecting valve disease
29 Mar, 2023 | 13:23h | UTC
Consensus Paper | Recommendations for the provision of infective endocarditis services
15 Mar, 2023 | 15:13h | UTC
RCT | Three-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis
14 Mar, 2023 | 13:47h | UTCThree-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis – Journal of the American College of Cardiology (link to abstract – $ for full-text)
News Release: Benefits of TAVR Remain Consistent in Patients at Low Surgical Risk at Three Years – American College of Cardiology
Commentary on Twitter
#ACC23/#WCCardio #JACC LBCT SimPub: Data from the Evolut Low Risk trial demonstrated that #TAVR at 3 years showed durable benefits compared with surgery with respect to all-cause mortality or disabling stroke. https://t.co/PtEEFI1P1t#vhdAS #SAVR #CardioTwitter @kashishgoelmd pic.twitter.com/x0milxBGxO
— JACC Journals (@JACCJournals) March 5, 2023
Cohort Study | Effect of prosthesis-patient mismatch on long-term clinical outcomes after bioprosthetic aortic valve replacement
10 Mar, 2023 | 14:32h | UTCSummary: The study examined the impact of prosthesis-patient mismatch (PPM) on long-term clinical outcomes following bioprosthetic surgical aortic valve replacement (SAVR). The observational cohort study analyzed data from 16,423 patients who underwent bioprosthetic SAVR in Sweden from 2003 to 2018.
Results showed that increasing grades of PPM were associated with higher long-term mortality and heart failure hospitalization. Severe PPM was linked to an increased risk of heart failure, but moderate PPM did not have significant clinical significance. The study also found that PPM was not associated with aortic valve reintervention. The incidence of moderate and severe PPM has decreased in Sweden since 2013 but remained common.
M-A | Risk of bias in randomized clinical trials comparing transcatheter and surgical aortic valve replacement
15 Feb, 2023 | 15:52h | UTCCommentary: Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends – TCTMD
Commentary on Twitter
Trials comparing TAVI vs SAVR show substantial proportions of deviation from assigned treatment, loss to follow-up, and additional procedures, as well as systematic selective imbalance favoring TAVI that might affect internal validity. https://t.co/n7hwTMEPGu
— JAMA Network Open (@JAMANetworkOpen) January 3, 2023
Review | Valvular heart disease: shifting the focus to the myocardium
7 Feb, 2023 | 13:37h | UTCValvular heart disease: shifting the focus to the myocardium – European Heart Journal
Commentary on Twitter
Valvular heart disease: shifting the focus to the myocardium https://t.co/u1Nu7nnQvq @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/QFM8BJItRl
— European Society of Cardiology Journals (@ESC_Journals) October 10, 2022
Retrospective Cohort | Long‐term clinical outcomes in patients with severe tricuspid regurgitation
2 Feb, 2023 | 14:53h | UTC
M-A | Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients
31 Jan, 2023 | 13:59h | UTCTranscatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials – European Heart Journal (free for a limited period)
Commentary on Twitter
Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials https://t.co/qiXE9VWx7K @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/IWeYHM0o6e
— European Society of Cardiology Journals (@ESC_Journals) January 30, 2023
Review | Mitral valve transcatheter edge-to-edge repair
31 Jan, 2023 | 13:40h | UTCMitral valve transcatheter edge-to-edge repair – EuroIntervention
Commentary on Twitter
This State of the Art describes the currently available M-TEER systems and summarises the evidence for M-TEER in both primary mitral regurgitation (PMR) and secondary mitral regurgitation (SMR). #EAPCI #CARDIOTWITTER https://t.co/HVIepnBazw pic.twitter.com/jrE2RO4JPe
— EuroIntervention (@EuroInterventio) January 28, 2023
Guideline | Recommendations for the use of echocardiography in the evaluation of rheumatic heart disease
30 Jan, 2023 | 00:59h | UTCCommentaries:
ASE releases updated rheumatic heart disease guideline – Cardiovascular Business
Role of ECHO Emphasized in Management of Rheumatic Heart Disease – HealthDay
Commentary on Twitter
NEW GUIDELINE: Read our newest #guideline, "Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease," in our January @JournalASEcho! https://t.co/Rf0BL3grm6 pic.twitter.com/tHCJDlzbqp
— American Society of Echocardiography (@ASE360) January 5, 2023
Review | Antithrombotic therapy after bioprosthetic aortic valve replacement
12 Jan, 2023 | 12:51h | UTC
Research Opportunities in the treatment of mitral valve prolapse: JACC Expert Panel.
14 Dec, 2022 | 15:10h | UTC
Global is Local | Rheumatic heart disease around the world (including your clinic).
8 Dec, 2022 | 12:39h | UTCRelated: Global burden of rheumatic heart disease: trends from 1990 to 2019 – Arthritis Research & Therapy
Review / Perspective | Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
13 Sep, 2022 | 13:18h | UTC
Commentary on Twitter
https://twitter.com/ESC_Journals/status/1526080012729864198
Cohort Study | Incidence, timing, and causes of late bleeding after TAVR.
13 Sep, 2022 | 13:10h | UTCIncidence, Timing, and Causes of Late Bleeding After TAVR in an Asian Cohort – JACC: Asia
Editorial: Late Bleeding Following TAVR in Japan: An Important Cause of Mortality – JACC: Asia
Commentary: Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI – TCTMD
AHA Scientific Statement | Management of infective endocarditis in people who inject drugs.
1 Sep, 2022 | 12:00h | UTCNews Release: Addiction management is key to treating heart infection in people who inject drugs – American Heart Association
Top Things to Know: Infective Endocarditis in People Who Inject Drugs – American Heart Association
Video: Management of Infective Endocarditis in People who Inject Drugs – American Heart Association
Commentaries:
AHA Addresses Infective Endocarditis in Injection Drug Users – HealthDay
Related: Management of Infective Endocarditis in People Who Inject Drugs – American College of Cardiology (the original article is paywalled but has an informative infographic)